These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18382350

  • 21. Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression.
    Coulibaly B, Nanni I, Quilichini B, Gaudart J, Metellus P, Fina F, Boucard C, Chinot O, Ouafik L, Figarella-Branger D.
    Hum Pathol; 2010 Jun; 41(6):815-23. PubMed ID: 20303140
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
    Järvelä S, Helin H, Haapasalo J, Järvelä T, Junttila TT, Elenius K, Tanner M, Haapasalo H, Isola J.
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
    [Abstract] [Full Text] [Related]

  • 24. HER 2 status in invasive breast cancer: immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization.
    Shirsat HS, Epari S, Shet T, Bagal R, Hawaldar R, Desai SB.
    Indian J Pathol Microbiol; 2012 Aug; 55(2):175-9. PubMed ID: 22771638
    [Abstract] [Full Text] [Related]

  • 25. Dual-colour chromogenic in-situ hybridization is a potential alternative to fluorescence in-situ hybridization in HER2 testing.
    Hwang CC, Pintye M, Chang LC, Chen HY, Yeh KY, Chein HP, Lee N, Chen JR.
    Histopathology; 2011 Nov; 59(5):984-92. PubMed ID: 22092410
    [Abstract] [Full Text] [Related]

  • 26. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB, Boisvert SL, Akhavanfard S, Oliva E, Dias-Santagata DC, Kojiro S, Horowitz NS, Iafrate AJ, Borger DR, Rueda BR.
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [Abstract] [Full Text] [Related]

  • 27. Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast.
    Shao MM, Zhang F, Meng G, Wang XX, Xu H, Yu XW, Chen LY, Tse GM.
    Histopathology; 2011 Aug; 59(2):264-73. PubMed ID: 21884205
    [Abstract] [Full Text] [Related]

  • 28. Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.
    Yan B, Yau EX, Choo SN, Ong CW, Yong KJ, Pang B, Salto-Tellez M.
    J Clin Pathol; 2011 Oct; 64(10):880-3. PubMed ID: 21757431
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
    Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Callaghan R, Benito R, Roldan P, Piquer J, Llacer J, Barbera J.
    Clin Neuropathol; 2005 Oct; 24(5):209-18. PubMed ID: 16167544
    [Abstract] [Full Text] [Related]

  • 32. Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status.
    Madrid MA, Lo RW.
    Breast Cancer Res; 2004 Oct; 6(5):R593-600. PubMed ID: 15318940
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F, Shen T, Prichard JW.
    Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
    [Abstract] [Full Text] [Related]

  • 37. Comparison of liquid based cytology and histology for the evaluation of HER-2 status using immunostaining and CISH in breast carcinoma.
    Sartelet H, Lagonotte E, Lorenzato M, Duval I, Lechki C, Rigaud C, Cucherousset J, Durlach A, Graesslin O, Abboud P, Doco-Fenzy M, Quereux C, Costa B, Polette M, Munck JN, Birembaut P.
    J Clin Pathol; 2005 Aug; 58(8):864-71. PubMed ID: 16049291
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
    Marks RA, Zhang S, Montironi R, McCarthy RP, MacLennan GT, Lopez-Beltran A, Jiang Z, Zhou H, Zheng S, Davidson DD, Baldridge LA, Cheng L.
    Prostate; 2008 Jun 15; 68(9):919-23. PubMed ID: 18409189
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.